Healthcare provider profile · identity verified

Nicholas A Van Lith, MD

Family Practice · ANCHORAGE, AK · NPI 1720466949

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	634	177
Levothyroxine Sodium	Levothyroxine Sodium	364	86
Lisinopril	Lisinopril	334	84
Amlodipine Besylate	Amlodipine Besylate	320	104
Losartan Potassium	Losartan Potassium	267	86
Rosuvastatin Calcium	Rosuvastatin Calcium	240	68
Metformin Hcl	Metformin Hcl	231	53
Tamsulosin Hcl	Tamsulosin Hcl	227	70
Omeprazole	Omeprazole	195	52
Gabapentin	Gabapentin	189	50
Pantoprazole Sodium	Pantoprazole Sodium	171	34
Hydrochlorothiazide	Hydrochlorothiazide	165	45
Metoprolol Succinate	Metoprolol Succinate	145	38
Allopurinol	Allopurinol	124	42
Eliquis	Apixaban	108	27
Montelukast Sodium	Montelukast Sodium	102	33
Trazodone Hcl	Trazodone Hcl	101	36
Metformin Hcl Er	Metformin Hcl	99	25
Ozempic	Semaglutide	97	26
Fluoxetine Hcl	Fluoxetine Hcl	94	suppressed
Simvastatin	Simvastatin	94	22
Famotidine	Famotidine	90	16
Furosemide	Furosemide	85	20
Bupropion Xl	Bupropion Hcl	82	16
Jardiance	Empagliflozin	73	22
Pravastatin Sodium	Pravastatin Sodium	72	28
Quetiapine Fumarate	Quetiapine Fumarate	70	suppressed
Spironolactone	Spironolactone	69	19
Escitalopram Oxalate	Escitalopram Oxalate	67	24
Duloxetine Hcl	Duloxetine Hcl	63	14
Finasteride	Finasteride	63	12
Clopidogrel	Clopidogrel Bisulfate	62	16
Ezetimibe	Ezetimibe	61	15
Fenofibrate	Fenofibrate	59	suppressed
Citalopram Hbr	Citalopram Hydrobromide	58	suppressed
Donepezil Hcl	Donepezil Hcl	58	14
Sertraline Hcl	Sertraline Hcl	57	17
Ipratropium Bromide	Ipratropium Bromide	56	27
Albuterol Sulfate Hfa	Albuterol Sulfate	55	31
Alendronate Sodium	Alendronate Sodium	55	18
Triamcinolone Acetonide	Triamcinolone Acetonide	53	29
Valsartan	Valsartan	53	14
Synthroid	Levothyroxine Sodium	52	19
Benztropine Mesylate	Benztropine Mesylate	51	suppressed
Carvedilol	Carvedilol	50	11
Mounjaro	Tirzepatide	50	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	16
Fluticasone Propionate	Fluticasone Propionate	48	14
Potassium Chloride	Potassium Chloride	44	17
Prednisone	Prednisone	43	20
Dutasteride	Dutasteride	42	12
Glipizide	Glipizide	40	suppressed
Memantine Hcl	Memantine Hcl	40	suppressed
Pregabalin	Pregabalin	40	11
Tizanidine Hcl	Tizanidine Hcl	39	24
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	13
Chlorthalidone	Chlorthalidone	37	suppressed
Celecoxib	Celecoxib	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Estradiol	Estradiol	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Irbesartan	Irbesartan	31	11
Xarelto	Rivaroxaban	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	14
Ondansetron Odt	Ondansetron	30	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	14
Fluvoxamine Maleate	Fluvoxamine Maleate	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Meloxicam	Meloxicam	25	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	12
Valacyclovir	Valacyclovir Hcl	24	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	12
Januvia	Sitagliptin Phosphate	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Ursodiol	Ursodiol	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Nystatin	Nystatin	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Cephalexin	Cephalexin	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Baclofen	Baclofen	16	suppressed
Diazepam	Diazepam	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Tadalafil	Tadalafil	16	suppressed
Atenolol	Atenolol	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Premarin	Estrogens, Conjugated	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Risperidone	Risperidone	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Progesterone	Progesterone, Micronized	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error